Effect of ureastibamine on Leishmania donovani amastigote
- PMID: 2397943
Effect of ureastibamine on Leishmania donovani amastigote
Abstract
Ureastibamine, a pentavalent antimonial, reduced the parasitic load in the 60-day model of infection of L. donovani in hamsters. It also inhibited the in vivo multiplication of I donovani amastigotes in hamster peritoneal macrophages. No inhibition in either promastigote multiplication or amastigotes transformation was noted with filtrate obtained after incubation of the drugs for 72 h in the macrophage culture. Incubation of macrophages with ureastibamine revealed an impairment in the uptake of deoxyglucose. The effect of ureastibamine was compared with that of another pentavalent antimonial, sodium stibogluconate. It is suggested that impairment of macrophage membrane may contribute towards the adverse effect of these drugs against the intracellular parasite.
Similar articles
-
Urea stibamine: an improved method of preparation and its antileishmanial activity.Biochem Med Metab Biol. 1987 Aug;38(1):47-56. doi: 10.1016/0885-4505(87)90061-2. Biochem Med Metab Biol. 1987. PMID: 2444239
-
In vitro and in vivo leishmanicidal activity of Dysoxylum binectariferum and its fractions against Leishmania donovani.Phytomedicine. 2007 Jan;14(1):36-42. doi: 10.1016/j.phymed.2005.10.002. Epub 2005 Nov 15. Phytomedicine. 2007. PMID: 17190644
-
In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.Exp Parasitol. 2013 Sep;135(1):126-33. doi: 10.1016/j.exppara.2013.06.006. Epub 2013 Jul 3. Exp Parasitol. 2013. PMID: 23830987
-
Visceral leishmaniasis: experimental models for drug discovery.Indian J Med Res. 2011 Jan;133(1):27-39. Indian J Med Res. 2011. PMID: 21321417 Free PMC article. Review.
-
Recent advances in understanding Leishmania donovani infection: The importance of diverse host regulatory pathways.IUBMB Life. 2018 Jul;70(7):593-601. doi: 10.1002/iub.1759. Epub 2018 Apr 23. IUBMB Life. 2018. PMID: 29684241 Review.